Digital Biomarker Market Size, Share, Growth, And Industry Analysis, By Type (Passive Digital Biomarker, and Active Digital Biomarker), By Application (Clinical Disease, and Daily Health), Regional Insights, and Forecast To 2032

• 

   Request a Free Sample To Get More Information on this Market

Digital Biomarker Market Report Overview

The global digital biomarker market size was USD 1.28 billion in 2023 and the market is projected to touch USD 248.04 billion by 2032 at a CAGR of 82.5% during the forecast period.

With the help of various sensors, machine learning (ML), and artificial intelligence (AI) techniques, digital biomarkers are used to track morphological, psychological, and behavioral changes in the human body. The data is then made accessible to the wearer and other interested users. Currently, the biomarkers are primarily responsible for the big data insights produced in the healthcare sector. They aid in examining current health issues as well as those that are likely to deteriorate or become dangerous. Wearable, portable, digestible, and implanted gadgets are all types of available technology.

Several reasons have contributed to the enormous rise of the biomarker industry. First, the ability to gather and analyze substantial amounts of health data has become easier due to developments in wearable technology and mobile health technologies. Second, there is a demand for electronic biomarkers to monitor and manage chronic diseases due to the rising prevalence of these conditions and the need for personalized healthcare solutions. The accuracy and predictive power of the biomarkers have also been enhanced by the incorporation of artificial intelligence and machine learning algorithms, further promoting market expansion.

COVID-19 Impact: Rise in Demand for Telehealth Services Led to a Prompt Rise in the Use of the Biomarkers

The COVID-19 pandemic has benefited the industry for electrical biomarkers in a number of ways. First, the pandemic had considerably raised the demand for telehealth services and remote patient monitoring, which prompted a rise in the use of biomarkers. With the use of these biomarkers, COVID-19 symptoms and vital signs could be monitored in real-time, allowing medical personnel to remotely evaluate patient health and take appropriate action. Secondly, the epidemic also sped up the creation and adoption of digital health solutions, including wearable technology and mobile health software. The biomarkers were frequently used in these technologies to monitor COVID-19-related symptoms such as temperature, heart rate, respiration rate, and oxygen saturation levels.

Latest Trends

"Partnership Between Firms Developed to Accelerate the Creation of Biomarkers for ALS "

A renowned supplier of electronic biomarkers is aiming to break into the market by making a strategic purchase, which would allow it to have access to a wider variety of goods and increase overall sales. For instance, in March 2022, Mitsubishi Tanabe Pharma America (MTHA) and Everything ALS, a charitable organization dedicated to overcoming the gap amongst consumers, technological advances, and research, partnered. Through this partnership, the creation of digital biomarkers for ALS (amyotrophic lateral sclerosis) is intended to be accelerated.

Digital Biomarker Market Segmentation

• By Type Analysis

According to type, the market can be segmented into passive digital biomarker, and active digital biomarker.

• By Application Analysis

Based on application, the market can be divided into clinical disease, and daily health.

Driving Factors

"Advancements in Technology is Significantly Driving the Market Growth"

A significant driver of the digital biomarker market growth is the ongoing progress of technology, particularly in the areas of wearable technology, sensor technologies, mobile health applications, and artificial intelligence (AI). The precision, dependability, and accessibility of the biomarkers have considerably increased as a result of these developments. Wearable technology includes sensors that may gather a variety of physiological data, including heart rate, sleep patterns, activity levels, and even biochemical markers. A few instances of wearable technology include smartwatches and fitness trackers. These data points can be utilized as electrical biomarkers to track health problems, identify illness early warning indications, and offer individualized healthcare insights. Additionally, the use of AI and machine learning algorithms enables more complex data analysis and interpretation, improving the prognostic capacities of the biomarkers.

"Growing Demand for Personalized Healthcare is Contributing to the Rising Need for More Biomarkers"

The desire for more accurate and targeted treatment methods, aging populations, and the increased prevalence of chronic diseases are some of the factors contributing to the rising need for personalized healthcare solutions. Digital biomarkers present a singular chance to continually record personal health data, enabling a deeper comprehension of a person's health condition, illness progression, and treatment response. Healthcare professionals can remotely monitor patients, customize therapies based on real-time data, and make better decisions on individualized treatment plans by utilizing these biomarkers. The market is expanding significantly due to the demand for personalized healthcare.

Restraining Factors

"Concerns Over Data Privacy and Security Are Limit the Industry Expansion"

The concern over data privacy and security is one barrier to the market for electronic biomarkers. Sensitive health information is collected and transmitted by the biomarkers, which increases the danger of data breaches and unauthorized access. Individuals, healthcare professionals, and regulatory agencies are concerned about the possible misuse or improper treatment of personal health information. For the widespread use of electronic biomarkers and to solve the limiting factor of data privacy and security, it is crucial to maintain strong data protection measures, ensure compliance with privacy laws, and build trust in data security.

• 

   Request a Free Sample To Get Analysis on Major Geographic Market
•  

Digital Biomarker Market Regional Insights

"Large Population and Burden of Disease Are Driving the Demand for the Biomarkers in the Region"

A large chunk of the world's population resides in the Asia Pacific, including populous nations such as China and India. The area has a higher burden of disease due to its larger population, including chronic problems such as cardiovascular disease, diabetes, and respiratory disorders. Electrical biomarkers have been adopted as a technique to enhance healthcare outcomes in this region due to the necessity for efficient disease management and monitoring. The advantages of digital health technologies, such as remote monitoring and personalized healthcare, are becoming more widely known among people in the Asia Pacific area. There is a growing need for biomarkers that can enable people to actively monitor their health and make educated decisions, as smartphone usage is booming and the general population is becoming more tech-savvy. This demand-driven market growth has propelled Asia Pacific to dominate the digital biomarker market share.

Key Industry Players

"Key Players Are Investing in R&D to Improve the Reliability and Functionality of the Devices "

Players are concentrating on a number of techniques to rule the biomarker sector. To improve the reliability and functionality of the biomarkers, they are making significant investments in research and development. To increase market penetration, cooperation with pharmaceutical firms, healthcare providers, and technological partners is being sought for. In order to enhance data analysis and forecasting capacities, players are also utilizing artificial intelligence and machine learning technologies. To ensure compliance and foster trust, they are also aggressively seeking regulatory approvals and certifications. To achieve a competitive edge, marketing strategies are used. These include awareness campaigns and targeted promotions.

LIST OF TOP DIGITAL BIOMARKER COMPANIES

• Philips (The Netherlands
• Johnson & Johnson (U.S.)
• Pfizer (U.S.)
• GE Healthcare (U.S.)
• Novartis (Switzerland)

Report Coverage

This report covers the digital biomarker market. The CAGR expected to be in during the forecast period, and also the USD value in 2023 and what it is expected to be in 2032. The effect COVID-19 had on the market in the beginning of the pandemic. The latest trends taking place in this industry. The factors that are driving this market as well as the factors that are restraining the growth of industry. The segmentation of this market based on type and applications. The region leading in the industry and why they will continue to do so during the forecast period. Further, the key market players, what all is being done by them to stay ahead of their competition as well as retain their market positions. All these details are covered in the report.